
While pediatric oncologist Daniel “Trey” Lee was working at the NIH, he tested a form of gene therapy as a possible way to save children with leukemia. Now at UVA, Lee just gave the first dose of an experimental immunotherapy to a 14-year-old with acute lymphoblastic leukemia.